- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BGF MDI HFA 320/14.4/9.6 μg
Total 28 results
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Germany, Argentina, Bulgaria, Poland, Turkey, Mexico, United Kingdom
-
Pearl Therapeutics, Inc.CompletedCOPDUnited States, Austria, Canada, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom, Peru, Russian Federation, Hungary, China, Taiwan, Australia, Japan, Argentina, South Africa, Belgium, Czechia, Serbia, Poland, Mexico, New... and more
-
Pearl Therapeutics, Inc.Completed
-
AstraZenecaRecruitingAsthmaUnited States, China, Czechia, Germany, South Africa, United Kingdom, Mexico, Turkey, Colombia, Russian Federation, Brazil, Israel, Greece, Portugal, Austria, Costa Rica, Saudi Arabia, Slovakia, Sweden, Puerto Rico
-
AstraZenecaRecruitingAsthmaUnited States, Canada, Denmark, Hungary, New Zealand, Poland, Spain, Korea, Republic of, Philippines, Italy, Argentina, Bulgaria, India, Japan, Vietnam, Taiwan, Thailand, Peru, Chile, Puerto Rico, Belgium, Australia, Netherlands, Romania
-
AstraZenecaRecruitingCOPD (Chronic Obstructive Pulmonary Disease)France, Denmark, Italy, Spain, United States, Canada, Argentina, Japan, Colombia, Germany, Peru, Brazil, China, India, Thailand, Austria, Serbia, Malaysia, Philippines, Poland, Taiwan, Greece, Norway, Sweden, Mexico, Romania, Korea, Republic... and more
-
Pearl Therapeutics, Inc.Completed
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Pearl Therapeutics, Inc.WithdrawnChronic Obstructive Pulmonary Disease
-
AstraZenecaRecruitingAsthmaUnited States, Canada, Italy, Japan, Vietnam, Spain, Germany, Malaysia
-
AstraZenecaRecruitingCOPD (Chronic Obstructive Pulmonary Disease)United States, Korea, Republic of, Argentina, Turkey, Vietnam, Malaysia, Philippines, Thailand, Hungary, Mexico, Canada, India, Bulgaria, Poland
-
AstraZenecaRecruitingAsthmaUnited States, Canada, South Africa, Korea, Republic of, Philippines, Czechia, Malaysia, Germany
-
Pearl Therapeutics, Inc.CompletedCOPD, Chronic Obstructive Pulmonary DiseaseBelgium
-
AstraZenecaParexelNot yet recruiting
-
AstraZenecaRecruitingChronic Obstructive Pulmonary DiseaseGermany, United Kingdom
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DisorderUnited States, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Czechia
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DisorderUnited States, Austria, Belgium, Canada, Denmark, Germany, Italy, Spain, Sweden, United Kingdom, Peru, Brazil, South Africa, Argentina, Russian Federation, Mexico, Puerto Rico, Chile, Norway
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseChina
-
AstraZenecaParexelCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Pearl Therapeutics, Inc.Completed
-
AstraZenecaParexelCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
GlaxoSmithKlineCompletedRespiratory Syncytial Virus InfectionsFinland, Spain, Canada, United States, Korea, Republic of
-
AstraZenecaParexelCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Lupin, Inc.CompletedMild Persistent AsthmaUnited States
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUnknownEnd Stage Renal DiseaseSpain, France, Italy, Belgium
-
AstraZenecaIqvia Pty Ltd; Premier Inc.Withdrawn
-
Chiesi Farmaceutici S.p.A.Completed
-
National Cancer Institute (NCI)RecruitingDown Syndrome | B Acute Lymphoblastic Leukemia | B Lymphoblastic LymphomaUnited States, Canada, Puerto Rico, Australia, New Zealand